Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Calvin Life Science AB
AB
Active
Org 5593292708
Själbodgatan 2 B
Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 172K
+24% vs 2024
EBITDA margin
4.1%
0% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK 7K
0% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 172K
+24%
EBITDA
SEK 7K
+0%
Net profit
SEK 7K
+0%
Total assets
SEK 24K
-45%
Equity
SEK 24K
+71%
Employees
0
—
Company information
Legal name
Calvin Life Science AB
Org number
5593292708
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
30 juli 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsult inom Life Science, internationell handel med läkemedel och medicintekniska produkter. Handel med aktier och värdepapper.
Contact
Address
Själbodgatan 2 B
Email
calvinlifescience@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other financial service activities, except insurance and pension funding n.e.c.
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
0
—
139
172
Staff expenses
—
—
—
—
EBITDA
6
0
7
7
Depreciation & amort.
−0
—
−0
−0
EBIT
6
0
7
7
Net financials
—
—
—
—
Profit before tax
6
0
7
7
Tax
−2
—
−0
−0
Net profit
4
—
7
7
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
47
—
44
24
Equity
45
—
14
24
Long-term debt
0
—
12
0
Short-term debt
2
—
18
0
Total debt
2
—
30
—
Financial ratios
5-year trend
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
2022
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2022
2025
Return on equity
29.2%
This company
18.4%
Market median
+59% vs market
2022
2025
Net profit margin
4.1%
This company
8.1%
Market median
-49% vs market
2022
2025
Asset turnover
7.17×
This company
1.12×
Market median
+540% vs market
2022
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
CL
Christine Lacoste
Chief Executive Officer
Chief Executive Officer
2022 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
JM
Johan Magnus Månsson
Board of Directors
2026
NA
Nils Axel Jens Månsson
Deputy Board Member
2022
CA
Carl Alexander Piirainen
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Calvin Life Science AB also hold positions in
0
other companies.
Person
Role here
Other companies
Christine Lacoste
Chief Executive Officer
0 companies
Johan Magnus Månsson
Board of Directors
0 companies
Nils Axel Jens Månsson
Deputy Board Member
0 companies
Carl Alexander Piirainen
Deputy Board Member
0 companies